Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
22/05/2024 | 18:05 | Business Wire | Proposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc Litigation | NYSE:JNJ | Johnson and Johnson |
21/05/2024 | 16:43 | Edgar (US Regulatory) | Form CERT - Certification by an exchange approving securities for listing | NYSE:JNJ | Johnson and Johnson |
20/05/2024 | 23:17 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:JNJ | Johnson and Johnson |
20/05/2024 | 22:34 | Edgar (US Regulatory) | Form 8-A12B - Registration of securities [Section 12(b)] | NYSE:JNJ | Johnson and Johnson |
20/05/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
20/05/2024 | 15:31 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | NYSE:JNJ | Johnson and Johnson |
17/05/2024 | 13:36 | IH Market News | OpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More News | NYSE:JNJ | Johnson and Johnson |
16/05/2024 | 22:16 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NYSE:JNJ | Johnson and Johnson |
16/05/2024 | 13:30 | Business Wire | Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment | NYSE:JNJ | Johnson and Johnson |
14/05/2024 | 23:01 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses | NYSE:JNJ | Johnson and Johnson |
14/05/2024 | 13:26 | IH Market News | Walmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More News | NYSE:JNJ | Johnson and Johnson |
14/05/2024 | 12:05 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NYSE:JNJ | Johnson and Johnson |
10/05/2024 | 23:14 | Edgar (US Regulatory) | Form 13F-HR - Quarterly report filed by institutional managers, Holdings | NYSE:JNJ | Johnson and Johnson |
08/05/2024 | 22:30 | Business Wire | Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | NYSE:JNJ | Johnson and Johnson |
06/05/2024 | 22:05 | GlobeNewswire Inc. | Shockwave Medical Reports First Quarter 2024 Financial Results | NYSE:JNJ | Johnson and Johnson |
01/05/2024 | 12:30 | Business Wire | Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization | NYSE:JNJ | Johnson and Johnson |
22/04/2024 | 22:30 | Business Wire | Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) | NYSE:JNJ | Johnson and Johnson |
19/04/2024 | 13:31 | IH Market News | Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More | NYSE:JNJ | Johnson and Johnson |
17/04/2024 | 12:59 | IH Market News | US Index Futures See Gains, Oil Prices Dip | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 22:33 | IH Market News | U.S. Stocks Finish Lackluster Session Narrowly Mixed | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 16:46 | Business Wire | CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 15:52 | IH Market News | J&J’s Q1 2024 sales rise 2.3% to $21.4 billion | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 15:09 | IH Market News | Dow Looks To Snap Six-Day Losing Streak As UnitedHealth Surges | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 13:19 | IH Market News | U.S. Index Futures Signal Mixed Trading, Oil Prices Dip | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 13:18 | IH Market News | Ericsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More News | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 12:25 | Business Wire | Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | NYSE:JNJ | Johnson and Johnson |
16/04/2024 | 12:20 | Business Wire | Johnson & Johnson Reports Q1 2024 Results | NYSE:JNJ | Johnson and Johnson |
15/04/2024 | 22:38 | IH Market News | U.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales Data | NYSE:JNJ | Johnson and Johnson |
09/04/2024 | 00:06 | Business Wire | Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference | NYSE:JNJ | Johnson and Johnson |
06/04/2024 | 05:21 | PR Newswire (US) | CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy | NYSE:JNJ | Johnson and Johnson |